Most malignant carcinomas such as myeloid leukemia, colon, skin, head and neck carcinoma, and breast carcinoma present high, sustained, constitutive expression of DDIT4 with poor prognosis [34,35]. This evidence concerns the gene DDIT4 and head and neck carcinoma.